BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 16029783)

  • 1. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR; Chen PY; Vicini FA; Wallace M; Kestin L; Edmundson G; Gustafson G; Martinez A
    Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
    Pignol JP; Rakovitch E; Keller BM; Sankreacha R; Chartier C
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1482-8. PubMed ID: 18930602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma.
    Chen PY; Vicini FA; Benitez P; Kestin LL; Wallace M; Mitchell C; Pettinga J; Martinez AA
    Cancer; 2006 Mar; 106(5):991-9. PubMed ID: 16421922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
    Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM; Berson AM; Rescigno J; Sanghavi S; Siegel B; Axelrod D; Bernik S; Scarpinato V; Mills C
    Ann Surg Oncol; 2004 Aug; 11(8):739-46. PubMed ID: 15249336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M; Martinez A; Mitchell C; Chen PY; Ghilezan M; Benitez P; Brown E; Vicini F
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):531-6. PubMed ID: 19775830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial breast irradiation as second conservative treatment for local breast cancer recurrence.
    Hannoun-Levi JM; Houvenaeghel G; Ellis S; Teissier E; Alzieu C; Lallement M; Cowen D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1385-92. PubMed ID: 15590169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.
    Dickler A; Kirk M; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):469-74. PubMed ID: 15145164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
    Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP
    Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
    Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
    Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.